Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals’ (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...
Investing.com - Apple reported first-quarter results Thursday that topped Wall Street analysts as stronger services revenue ...
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback